Kidney Replacement Therapy
Patient education, tailored support can promote home dialysis in certain adults
Patient-centered education and tailored support can promote an uptake of home dialysis among self-identified Hispanic or Latino adults receiving in-center dialysis, according to results of a qualitative study.
Rate of kidney replacement therapy for primary glomerular disease varies by country
Rate of kidney replacement therapy for end-stage kidney disease due to primary glomerular disease varies between European countries and was highest for immunoglobulin A nephropathy and focal segmental glomerulosclerosis, study data show.
Decision factors for pediatric kidney replacement therapies may differ from guidelines
Level of kidney function, rate of decline and type of renal disease are key factors influencing the decision to initiate kidney replacement therapy, whether dialysis or transplantation, for pediatric patients, according to study data.
Hemodiafiltration associated with better quality of life than hemodialysis
Adults with chronic kidney disease managed with hemodiafiltration reported less drop in health-related of quality of life, particularly in cognitive decline, compared with those using hemodialysis, according to data from the CONVINCE trial.
Slowing diabetic kidney disease progression may cut health costs for veterans
Slowing the progression to advanced diabetic kidney disease could lower the economic impact of the condition and help health care systems optimize resources, recently published data show.
Researchers identify possible genetic risk linked to AKI in patients with kidney disease
Researchers have identified two loci that may be associated to AKI in hospitalized patients with kidney disease, noting a potential genetic risk of the condition, data show.
Chinese American patients in ICU less likely to get kidney replacement therapy
Critically ill Chinese American patients in an ICU were less likely to receive kidney replacement therapy at the end of life compared with patients researchers described as white Americans, published data show.
Study: Semaglutide slowed progression of CKD, cut cardiovascular events, mortality risk
Use of the drug semaglutide in patients with type 2 diabetes significantly reduced the risk of major kidney disease events, cardiovascular outcomes and all-cause mortality vs. placebo, newly published data show.
‘Critical gap’ exists between recommended, prevalent nephrology practices
A “critical gap” between recommended and commonly used nephrology practices, including kidney replacement therapy-directed education, exists, according to a published study.
Patients with CKD have limited success with shared decision-making
Patients with chronic kidney disease have limited opportunities to engage in shared-decision-making with their physicians, according to a published Danish study.